Neuropsychology of Financial Capacity

NCT05791006 | Unknown

• 1 other identifier: 25C121
• Study Type: observational
• Target: 99
• Locations: 1 country
• Sites: 1

Brief Summary

The present project aims to investigate the financial capacity in patients diagnosed with Parkinson's Disease or parkinsonism, brain tumor (glioma or meningioma) and cerebrovascular lesion (stroke), in order to evaluate the presence and degree of impairment, and the role of some factors as potential predictors of financial incapacity. The term 'financial capacity' means both operations relating, for example, to asset management or investing money, and activities of daily life such as shopping or using small sums of money; these activities are mediated by different cognitive functions, from numerical and arithmetic skills to decision making. Financial capacity is, in fact, an instrumental activity of daily life (i.e. Instrumental Activity Of Daily Living, I-ADL) whose impairment negatively affects the functional autonomy of the individual, so as to be subject to legal protection. To assess financial capacity, the Numerical Activities of Daily Living - Financial (NADL-F; Arcara et al., 2017) will be administered, a battery of tests aimed at investigating both financial performance and financial competence according to the most recent neuropsychological models proposed in the literature.

Conditions

Parkinson Disease; Brain Tumor; Stroke

Outcome Measures

Primary Outcomes (6)

• Numerical Activity of Daily Living Financial (NADL-F) in Patients with Parkinson's Disease/Parkinsonisms

  Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities

  At baseline

• Numerical Activity of Daily Living Financial (NADL-F) in Patients with ischemic or haemorrhagic stroke

  Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities

  At baseline

• Change from baseline in Numerical Activity of Daily Living - Financial (NADL-F)Patients with brain tumors

  Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities

  At 3 and 12 months follow up

• Montreal Cognitive Assessment (MoCA)

  Assessment of global cognitive functioning

  At baseline

• Frontal Assessment Battery (FAB)

  Assessment of global cognitive functioning

  At baseline

• Activities of daily living questionnaire (ADL)

  Assessment of function independence in everyday life

  At baseline

Study Arms (4)

Patients with Parkinson's Disease/Parkinsonisms

Behavioral: Neuropsychological tests

Patients with brain tumors

Behavioral: Neuropsychological tests

Patients with ischemic or haemorrhagic stroke

Behavioral: Neuropsychological tests

Healthy Controls

Behavioral: Neuropsychological tests

Interventions

Neuropsychological tests BEHAVIORAL

Neuropsychological assessment with: * NADL-F * Frontal Assessment Battery (FAB) * functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) * Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients * Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients

Healthy Controls; Patients with Parkinson's Disease/Parkinsonisms; Patients with brain tumors; Patients with ischemic or haemorrhagic stroke

Eligibility Criteria

• Age: 18 Years - 99 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

* Patients with Parkinson's Disease/parkinsonisms * Patients with brain tumor * Patients with stroke * Healthy controls

You may qualify if:

• age \> 18 years
• Clinical diagnosis of interest for clinical groups
• For stroke patients: disease duration \> 1 month

You may not qualify if:

• Other brain disorders different from those of interest
• Sensory-motor deficits that could prevent neuropsychological assessment
• Language disorders that could prevent neuropsychological assessment
• Global cognitive impairment as indexed by MoCA \< 26 or MMP \< 22.85

Sponsors & Collaborators

• Istituto Auxologico Italiano: lead

Study Sites (1)

Istituto Auxologico Italiano IRCCS

Milan, Lombardy, 20122, Italy

RECRUITING

Related Publications (1)

• Arcara G, Burgio F, Benavides-Varela S, Toffano R, Gindri P, Tonini E, Meneghello F, Semenza C. Numerical Activities of Daily Living - Financial (NADL-F): A tool for the assessment of financial capacities double dagger. Neuropsychol Rehabil. 2019 Aug;29(7):1062-1084. doi: 10.1080/09602011.2017.1359188. Epub 2017 Sep 7.

  PMID: 28880732 BACKGROUND

MeSH Terms

Conditions

Parkinson Disease; Brain Neoplasms; Stroke

Interventions

Neuropsychological Tests

Condition Hierarchy (Ancestors)

Parkinsonian Disorders; Basal Ganglia Diseases; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Movement Disorders; Synucleinopathies; Neurodegenerative Diseases; Central Nervous System Neoplasms; Nervous System Neoplasms; Neoplasms by Site; Neoplasms; Cerebrovascular Disorders; Vascular Diseases; Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Psychological Tests; Behavioral Disciplines and Activities

Central Study Contacts

Nadia Bolognini, PhD

CONTACT

+39025821; n.bolognini@auxologico.it

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: March 5, 2023
• First Posted: March 30, 2023
• Study Start: August 4, 2021
• Primary Completion: November 30, 2024
• Study Completion: November 30, 2024
• Last Updated: March 30, 2023

Record last verified: 2023-03

Locations

IT (1)